关键词：ALS；卢伽雷病；进行性神经变性疾病；失去；启动；控制；肌肉
摘 要：ALS, often referred to as Lou Gehrig's disease, is a progressive neurodegenerative disease that affects neurons in the brain and spinal cord. In ALS, degeneration of the motor neurons leads to their death. As a result the brain loses its ability to initiate and control muscle movement. Patients in the later stages of the disease may turn out to be totally paralyzed. Muscle twitches, cramps, tight and stiff muscles, slurred and nasal speech, and difficulties in chewing or swallowing are some of the common symptoms observed in ALS patients.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Geographical Segmentation

08. Buying Criteria

09. Rate of Incidence and Prevalence

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

16.1 Competitive Scenario

16.1.1 Key News

16.1.2 Mergers and Acquisitions

16.2 Other Prominent Vendors

16.3 Vendor Ranking 2013

17. Late Stage Pipeline Snapshot

18. Key Vendor Analysis

18.1 Covis Pharmaceutical Inc

18.1.1 Business Overview

18.1.2 Key Information

18.1.3 SWOT Analysis

18.2 Eisai Co. Ltd.

18.2.1 Business Overview

18.2.2 Key Information

18.2.3 SWOT Analysis

18.3 GlaxoSmithKline plc

18.3.1 Business Overview

18.3.2 Business Segmentation

18.3.3 Key Information

18.3.4 SWOT Analysis

18.4 Mitsubishi Tanabe Pharma Corp.

18.4.1 Business Overview

18.4.2 Business Segmentation

18.4.3 Key Information

18.4.4 SWOT Analysis

19. Other Reports in this Series